🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

RxSight, Inc.

RXST Healthcare
$5.19 $-0.18 (-3.35%)
Market Cap: $214.85 M
Gurus Holding
5
Popularity Rank
#1937
% of Shares Held
3.99%
Net Activity (Q1 2026)
+$1.86 M

Guru Ownership Trend

Guru Analysis for RxSight, Inc. (RXST)

RxSight, Inc. (RXST), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.57 M.

Top institutional holders include Steven Cohen and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $1.86 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 682.0%. Conversely, Steven Cohen reduced exposure by 40.4%.

Key Holders

Recent Activity Breakdown (Q1 2026)

+$4.92 M
Total Buy Value
New Buys 2
Additions 2
-$3.06 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for RxSight, Inc. (RXST)

Major holders include Steven Cohen ($4.52 M), Cliff Asness ($3.92 M), Paul Tudor Jones ($929,914). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.65 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.86 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited RXST. The total reported sell value was $3.06 M.

Yes, 2 managers opened new positions in RXST, and 2 increased their existing holdings. The total reported buy value was $4.92 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% Reduce -40.4% 733,307 $4.52 M Q1 2026
0.00% Add 541.8% 636,129 $3.92 M Q1 2026
0.00% Add 682.0% 150,960 $929,914 Q1 2026
0.01% New Buy 70,062 $431,582 Q1 2026
0.00% New Buy 60,400 $372,064 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form